| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |